Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cantharidin is a terpenoid vesicant toxin originally isolated from blister beetles (notably *Lytta vesicatoria*). It is used medically as a topical treatment for molluscum contagiosum and viral warts due to its ability to induce acantholysis and blistering confined to epidermal cells. Upon application, it is absorbed by the lipids in the membranes of keratinocytes, triggering the release of neutral serine proteases that degrade desmosomal cell adhesion structures. This results in intraepidermal blister formation that helps detach viral lesions without scarring. Cantharidin is highly toxic if ingested and is classified as an extremely hazardous substance. In dermatology, it is usually formulated in low concentrations, alone or with other agents such as salicylic acid and podophyllin, but therapies must avoid mucosal, ocular, and oral contact due to systemic toxicity.
Absorbed by the lipid membranes of epidermal keratinocytes, leading to activation and release of neutral serine proteases, which break down desmosomal plaques (structures responsible for cell-to-cell adhesion in the epidermis), resulting in selective acantholysis and blister formation. Cantharidin is also a potent inhibitor of protein phosphatase 2A, which may contribute to additional biological effects (e.g., in vitro anticancer activity).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cantharidin.